Inflammation in AKI

Current understanding, key questions, and knowledge gaps

Hamid Rabb, Matthew D. Griffin, DIanne B. McKay, Sundararaman Swaminathan, Peter Pickkers, Mitchell H. Rosner, John A. Kellum, Claudio Ronco

Research output: Contribution to journalArticle

Abstract

Inflammation is a complex biologic response that is essential for eliminating microbial pathogens and repairing tissue after injury. AKI associates with intrarenal and systemic inflammation; thus, improved understanDing of the cellular and molecular mechanisms underlying the inflammatory response has high potential for identifying effective therapies to prevent or ameliorate AKI. In the past decade, much knowledge has been generated about the fundamental mechanisms of inflammation. Experimental work in small animal models has revealed many details of the inflammatory response that occurs within the kidney after typical causes of AKI, incluDing insights into the molecular signals released by dying cells, the role of pattern recognition receptors, the diverse subtypes of resident and recruited immune cells, and the phased transition from destructive to reparative inflammation. Although this expansion of the basic knowledge base has increased the number of mechanistically relevant targets of intervention, progress in developing therapies that improve AKI outcomes by modulation of inflammation remains slow. In this article, we summarize the most important recent developments in understanDing the inflammatorymechanisms ofAKI, highlight key limitations of the commonly used animal models and clinical trial designs that may prevent successful clinical application, and suggest priority approaches for research toward clinical translation in this area.

Original languageEnglish (US)
Pages (from-to)371-379
Number of pages9
JournalJournal of the American Society of Nephrology
Volume27
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Inflammation
Animal Models
Pattern Recognition Receptors
Knowledge Bases
Clinical Trials
Kidney
Wounds and Injuries
Therapeutics
Research

ASJC Scopus subject areas

  • Nephrology

Cite this

Rabb, H., Griffin, M. D., McKay, DI. B., Swaminathan, S., Pickkers, P., Rosner, M. H., ... Ronco, C. (2016). Inflammation in AKI: Current understanding, key questions, and knowledge gaps. Journal of the American Society of Nephrology, 27(2), 371-379. https://doi.org/10.1681/ASN.2015030261

Inflammation in AKI : Current understanding, key questions, and knowledge gaps. / Rabb, Hamid; Griffin, Matthew D.; McKay, DIanne B.; Swaminathan, Sundararaman; Pickkers, Peter; Rosner, Mitchell H.; Kellum, John A.; Ronco, Claudio.

In: Journal of the American Society of Nephrology, Vol. 27, No. 2, 01.02.2016, p. 371-379.

Research output: Contribution to journalArticle

Rabb, H, Griffin, MD, McKay, DIB, Swaminathan, S, Pickkers, P, Rosner, MH, Kellum, JA & Ronco, C 2016, 'Inflammation in AKI: Current understanding, key questions, and knowledge gaps', Journal of the American Society of Nephrology, vol. 27, no. 2, pp. 371-379. https://doi.org/10.1681/ASN.2015030261
Rabb, Hamid ; Griffin, Matthew D. ; McKay, DIanne B. ; Swaminathan, Sundararaman ; Pickkers, Peter ; Rosner, Mitchell H. ; Kellum, John A. ; Ronco, Claudio. / Inflammation in AKI : Current understanding, key questions, and knowledge gaps. In: Journal of the American Society of Nephrology. 2016 ; Vol. 27, No. 2. pp. 371-379.
@article{c90a163755574c87b2cc79368767f0c6,
title = "Inflammation in AKI: Current understanding, key questions, and knowledge gaps",
abstract = "Inflammation is a complex biologic response that is essential for eliminating microbial pathogens and repairing tissue after injury. AKI associates with intrarenal and systemic inflammation; thus, improved understanDing of the cellular and molecular mechanisms underlying the inflammatory response has high potential for identifying effective therapies to prevent or ameliorate AKI. In the past decade, much knowledge has been generated about the fundamental mechanisms of inflammation. Experimental work in small animal models has revealed many details of the inflammatory response that occurs within the kidney after typical causes of AKI, incluDing insights into the molecular signals released by dying cells, the role of pattern recognition receptors, the diverse subtypes of resident and recruited immune cells, and the phased transition from destructive to reparative inflammation. Although this expansion of the basic knowledge base has increased the number of mechanistically relevant targets of intervention, progress in developing therapies that improve AKI outcomes by modulation of inflammation remains slow. In this article, we summarize the most important recent developments in understanDing the inflammatorymechanisms ofAKI, highlight key limitations of the commonly used animal models and clinical trial designs that may prevent successful clinical application, and suggest priority approaches for research toward clinical translation in this area.",
author = "Hamid Rabb and Griffin, {Matthew D.} and McKay, {DIanne B.} and Sundararaman Swaminathan and Peter Pickkers and Rosner, {Mitchell H.} and Kellum, {John A.} and Claudio Ronco",
year = "2016",
month = "2",
day = "1",
doi = "10.1681/ASN.2015030261",
language = "English (US)",
volume = "27",
pages = "371--379",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - Inflammation in AKI

T2 - Current understanding, key questions, and knowledge gaps

AU - Rabb, Hamid

AU - Griffin, Matthew D.

AU - McKay, DIanne B.

AU - Swaminathan, Sundararaman

AU - Pickkers, Peter

AU - Rosner, Mitchell H.

AU - Kellum, John A.

AU - Ronco, Claudio

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Inflammation is a complex biologic response that is essential for eliminating microbial pathogens and repairing tissue after injury. AKI associates with intrarenal and systemic inflammation; thus, improved understanDing of the cellular and molecular mechanisms underlying the inflammatory response has high potential for identifying effective therapies to prevent or ameliorate AKI. In the past decade, much knowledge has been generated about the fundamental mechanisms of inflammation. Experimental work in small animal models has revealed many details of the inflammatory response that occurs within the kidney after typical causes of AKI, incluDing insights into the molecular signals released by dying cells, the role of pattern recognition receptors, the diverse subtypes of resident and recruited immune cells, and the phased transition from destructive to reparative inflammation. Although this expansion of the basic knowledge base has increased the number of mechanistically relevant targets of intervention, progress in developing therapies that improve AKI outcomes by modulation of inflammation remains slow. In this article, we summarize the most important recent developments in understanDing the inflammatorymechanisms ofAKI, highlight key limitations of the commonly used animal models and clinical trial designs that may prevent successful clinical application, and suggest priority approaches for research toward clinical translation in this area.

AB - Inflammation is a complex biologic response that is essential for eliminating microbial pathogens and repairing tissue after injury. AKI associates with intrarenal and systemic inflammation; thus, improved understanDing of the cellular and molecular mechanisms underlying the inflammatory response has high potential for identifying effective therapies to prevent or ameliorate AKI. In the past decade, much knowledge has been generated about the fundamental mechanisms of inflammation. Experimental work in small animal models has revealed many details of the inflammatory response that occurs within the kidney after typical causes of AKI, incluDing insights into the molecular signals released by dying cells, the role of pattern recognition receptors, the diverse subtypes of resident and recruited immune cells, and the phased transition from destructive to reparative inflammation. Although this expansion of the basic knowledge base has increased the number of mechanistically relevant targets of intervention, progress in developing therapies that improve AKI outcomes by modulation of inflammation remains slow. In this article, we summarize the most important recent developments in understanDing the inflammatorymechanisms ofAKI, highlight key limitations of the commonly used animal models and clinical trial designs that may prevent successful clinical application, and suggest priority approaches for research toward clinical translation in this area.

UR - http://www.scopus.com/inward/record.url?scp=84970924677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970924677&partnerID=8YFLogxK

U2 - 10.1681/ASN.2015030261

DO - 10.1681/ASN.2015030261

M3 - Article

VL - 27

SP - 371

EP - 379

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 2

ER -